Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
900 studies found for:    (psychotic disorders OR schizophrenia) AND (woman OR women OR female)
Show Display Options
RSS Create an RSS feed from your search for:
(psychotic disorders OR schizophrenia) AND (woman OR women OR female)
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Raloxifene as an Adjuvant Treatment of the Negative Symptoms of Schizophrenia in Post-menopausal Women
Condition: Negative Symptoms of Schizophrenia in Post-menopausal Women.
Interventions: Drug: Raloxifene;   Drug: Lactosa (placebo arm)
2 Completed Clinical Estradiol Trial in Women With Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder
Intervention: Drug: Estradiol
3 Completed Pilot Trial of Naltrexone for Obesity in Women With Schizophrenia
Conditions: Obesity;   Schizophrenia;   Schizoaffective Disorder
Interventions: Drug: Naltrexone 25mg;   Other: Placebo
4 Recruiting Selective Estrogen Receptor Modulators for Women of Child-bearing Age With Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder
Interventions: Drug: Raloxifene hydrochloride;   Drug: Placebo
5 Completed Homeopathic Medication and Nutritional Oriented Diet to Treat Overweight Pregnant Women With Mental Disorder
Conditions: Overweight;   Pregnancy;   Mental Disorder
Interventions: Drug: Sulph, Puls, Lyc, Lack t, Con, Sep, Nux v, Calc c, Phos;   Drug: Homeopathy and Nutritional oriented diet
6 Terminated Quality of Life (QOL) in Female Patient With Schizophrenia
Condition: Schizophrenia
Intervention: Drug: Quetiapine, Risperidone
7 Completed Double Blind, Placebo-controlled Study of Raloxifene for Negative Symptoms of Schizophrenia in Postmenopausal Women
Condition: Schizophrenia
Intervention: Drug: raloxifene
8 Recruiting Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With Schizophrenia
Condition: Hyperprolactinemia
Interventions: Drug: Aripiprazole;   Drug: Placebo
9 Completed Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: SEP-363856;   Drug: Placebo;   Drug: SEP-363856 Open Label
10 Completed A Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: SEP-363856;   Drug: Placebo
11 Active, not recruiting A Definitive Estrogen Patch Study (ADEPT)
Conditions: Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder(Not in Manic Phase)
Interventions: Drug: Estradiol;   Other: placebo
12 Completed Impact of Genetic Counseling for Female First Degree Relatives of Individuals With Mental Illness
Conditions: Schizophrenia;   Bipolar Disorder;   Schizoaffective Disorder
Intervention: Behavioral: Genetic Counseling
13 Completed
Has Results
Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to Risperidone
Condition: Schizophrenic Disorders
Interventions: Drug: Quetiapine XR;   Drug: Risperidone
14 Completed Pharmacokinetics, Effect of Food, Safety and Tolerability of a New Tablet Formulation of GSK1144814 in Healthy Subjects
Condition: Schizophrenia
Intervention: Drug: GSK1144814
15 Recruiting Study Assessing SEP-363856 in Male and Female Volunteers With High or Low Schizotype Characteristics
Condition: Schizophrenia
Interventions: Drug: SEP-363856;   Drug: Amisulpride;   Drug: Placebo
16 Completed Clinical Study Of Schizophrenia in Both Men and Women
Condition: Schizophrenia
Intervention: Drug: lamotrigine
17 Recruiting Omega-3 Dietary Supplements in Schizophrenia
Conditions: Schizophrenia;   Schizophreniform Disorder;   Schizoaffective Disorder;   Bipolar I
Interventions: Drug: Risperidone;   Drug: Omega-3 capsules;   Drug: Amber 50/50 Soybean/Corn Placebo
18 Withdrawn Glycine and D-Cycloserine in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: D-cycloserine;   Drug: Glycine;   Drug: Clozapine;   Drug: Placebo
19 Completed Treatment for First-Episode Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Olanzapine;   Drug: Risperidone
20 Completed Self-Management Therapy for Youth With Schizophrenia
Condition: Schizophrenia
Intervention: Behavioral: Self-management therapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years